The Food and Drug Administration Feb. 5 released an alert notifying patients of a safety concern using diabetes devices such ...

Developed by Northwestern Engineering’s Igor Efimov and George Washington University’s Luyao Lu, the implantable device uses ...

Senseonics announced today that it filed for CE mark for its Eversense 365 continuous glucose monitor (CGM) system.

Senseonics has filed to obtain CE Mark registration for its one-year continuous glucose monitoring (CGM) system, Eversense 365. The CE Mark submission aligns with the EU Medical Device Regulation (MDR ...

The US FDA warns users of smartphone-linked diabetes devices like CGMs and insulin pumps of potential health risks due to ...